Prof. Paul S. Eder is an accomplished biomedical scientist and diagnostics expert with extensive experience spanning academic research, biotechnology, industry, and global health. He has served as a Senior Scientific Officer in the Division of Microbiology and Infectious Diseases (DMID) at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), where he has led the Concept Acceleration Program for Diagnostics. Prof. Eder’s career has focused on the development, evaluation, and translation of innovative diagnostic technologies, particularly for infectious diseases and applications in resource-limited settings. Prior to joining NIAID, he served as a Senior Medical Diagnostics Advisor at the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Earlier, as Director of Assay Development at QIAGEN, he played a leading role in the development of the first World Health Organization-prequalified HPV screening test designed for use in resource-limited communities worldwide. He holds a PhD in Biochemistry from the University of Iowa and completed postdoctoral research at the University of Pennsylvania and Yale University, including work with Nobel laureate Sidney Altman. Prof. Eder is an inventor on multiple patents and has authored numerous scientific publications and reviews. His work reflects a strong commitment to translating scientific innovation into accessible and impactful diagnostic solutions for global health.